This case is aboutÂ ENTREPRENEURSHIP
PUBLICATION DATE: June 24, 2004
Acorda Therapeutics: Rebuilding the Spinal CordÂ Case Solution
Acorda is an early-stage life science start up with a promising product that is close to reaching the market (Phase III clinical trials).
The firm is grappling with the best way to enlarge its portfolio of molecules to make the business more sustainable. It faces classic in-licensing selections, what stage of growth, including what disorder indication, how many molecules, and on what terms.